Pricing medicines: theory and practice, challenges and opportunities
- 1 February 2005
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 4 (2) , 121-130
- https://doi.org/10.1038/nrd1633
Abstract
The pricing of medicines has become one of the most hotly debated topics of recent times, with the pharmaceutical industry seemingly being attacked from all quarters. From a company perspective, determining the price for each new product is more crucial than ever, given the present dearth of new drug introductions. But how are pricing strategies developed in practice? What is value-based pricing and how are financial models of return on investment constructed? What are the challenges faced in setting the price for a particular product, and how will scientific and environmental trends provide future pricing challenges or opportunities?Keywords
This publication has 3 references indexed in Scilit:
- The Drug Budget Silo Mentality in Europe: An OverviewValue in Health, 2003
- ‘Fourth hurdle reviews’, NICE, and database applicationsPharmacoepidemiology and Drug Safety, 2001
- Cost-Effectiveness in Health and MedicinePublished by Oxford University Press (OUP) ,1996